Resolving controversies on the path to Alzheimer's therapeutics (Q39709721)

14 September 2017

title

Resolving controversies on the path to Alzheimer's therapeutics (English)

1 reference

14 September 2017

0 references

1

Dennis J Selkoe

1 reference

14 September 2017

language of work or name

English

0 references

publication date

7 September 2011

1 reference

14 September 2017

1 reference

14 September 2017

volume

17

1 reference

14 September 2017

issue

9

1 reference

14 September 2017

page(s)

1060-1065

1 reference

https://scigraph.springernature.com/pub.10.1038/nm.2460

14 September 2017

exact match

0 references

cites work

Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

1 reference

12 December 2020

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

1 reference

12 December 2020

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

1 reference

12 December 2020

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

1 reference

12 December 2020

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

12 December 2020

PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses

1 reference

12 December 2020

Amyloid-independent mechanisms in Alzheimer's disease pathogenesis

1 reference

12 December 2020

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

1 reference

12 December 2020

Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice

1 reference

12 December 2020

Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology

1 reference

12 December 2020

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

1 reference

12 December 2020

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

1 reference

12 December 2020

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

1 reference

12 December 2020

Addressing Alzheimer's disease tangles: from NAP to AL-108.

1 reference

12 December 2020

Human apoE isoforms differentially regulate brain amyloid-β peptide clearance

1 reference

12 December 2020

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

1 reference

12 December 2020

Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

1 reference

12 December 2020

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

1 reference

12 December 2020

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

1 reference

12 December 2020

Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.

1 reference

12 December 2020

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

1 reference

12 December 2020

Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers

1 reference

12 December 2020

Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome

1 reference

12 December 2020

Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift

1 reference

12 December 2020

Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease

1 reference

12 December 2020

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

1 reference

12 December 2020

Alzheimer's disease: the challenge of the second century

1 reference

12 December 2020

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

1 reference

12 December 2020

Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus

1 reference

12 December 2020

APP processing and synaptic function

1 reference

12 December 2020

Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).

1 reference

12 December 2020

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

1 reference

12 December 2020

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

1 reference

12 December 2020

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

1 reference

12 December 2020

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

12 December 2020

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

1 reference

12 December 2020

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

12 December 2020

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.2460

1 reference

14 September 2017

1 reference